1 recruiting, 1 unknown. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Placebo device: new trials by email Literature Review of Placebo device trials Research Report on Placebo device
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Benefit of Transcutaneous Auricular Vagus Nerve Stimulation in Improving Quality of Life in First Line Treatment of Ovarian Cancer: transcutaneous auricular vagus nerve stimulation, Placebo device - Ovarian Carcinoma, First Line Chemotherapy | Phase 3 | Recruiting | Centre Francois Baclesse | 116 | 2025-04-30 | 2025-10-07 |
| Electromagnetic Fields Versus Placebo For Child-Pugh A and B Patients With Advanced Hepatocellular Carcinoma TheraBionic Device, Placebo Device, Quality of Life Assessment - Hepatocellular Carcinoma | Phase 2 / Phase 3 | Unknown | THERABIONIC INC. | 166 | 2023-07-01 | 2023-06-28 |
Carcinoma, Hepatocellular (1) · Digestive System Diseases (1) · Ovarian Neoplasms (1)
Centre Francois Baclesse (1) · THERABIONIC INC. (1)
France (1) · United States (1)
R44CA256984 (1)